Ads
related to: SARS-CoV-2
Search results
Roche Touts Mass Spec Launch, Instrument Upgrades, Upcoming Tests at Investor Day
GenomeWeb News· 1 day agoAt its investor presentation in London on Wednesday, Roche Diagnostics executives described the...
Latest COVID worry, FLiRT variants, sparks concern about vaccination rates
Los Angeles Daily News· 6 days agoA new family of COVID variants nicknamed “FLiRT” is spreading across the country, as vaccination...
Invivyd, Inc. (NASDAQ:IVVD) Expected to Earn Q2 2024 Earnings of ($0.46) Per Share
ETF DAILY NEWS· 7 days agoInvivyd, Inc. (NASDAQ:IVVD – Free Report) – HC Wainwright decreased their Q2 2024 earnings per share estimates for shares of Invivyd in a report released on Tuesday, May 14th. HC Wainwright ...
CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update
Digital Journal· 5 hours agoOrganizational redesign on track, trimming residual pandemic infrastructure and reducing 150 positions by year endU.S. FDA Fast Track designation granted for pre-pandemic avian influenza (H5N1 ...
TB has reclaimed its place as the world’s biggest infectious killer – but are its days numbered?
The Telegraph via Yahoo News· 4 days agoIn the few minutes it takes to read this article, some 15 people are likely to have died from...
How a simulation is informing COVID-19 vaccine policy after our 'return to normal'
Medical Xpress· 3 days agoBefore the emergence of the omicron COVID-19 variant, countries like the U.K. had high vaccination...
Kentucky Retirement Systems Insurance Trust Fund Sells 331 Shares of Hologic, Inc. (NASDAQ:HOLX)
ETF DAILY NEWS· 3 days agoKentucky Retirement Systems Insurance Trust Fund lessened its holdings in Hologic, Inc. (NASDAQ:HOLX – Free Report) by 3.7% in the fourth quarter, according to the company in its most recent ...
Invivyd appoints two new directors to its board By Investing.com
Investing.com· 1 day agoInvivyd Inc. (NASDAQ:IVVD), a biopharmaceutical company, announced the election of two new...
RedHill Biopharma (NASDAQ:RDHL) Coverage Initiated by Analysts at StockNews.com
ETF DAILY NEWS· 3 days agoStockNews.com started coverage on shares of RedHill Biopharma (NASDAQ:RDHL – Free Report) in a research note published on Monday. The brokerage issued a hold rating on the biotechnology company ...
CDC ending program for free COVID vaccines early for some
The Hill· 6 days agoThe federal government’s Bridge Access Program unveiled last year in anticipation of the COVID-19...